Journal of the Korean Ophthalmological Society 1995;36(3):378-385.
Published online March 1, 1995.
The Effects of Recombinant Human alpha-Interferon on Epidemic keratoconjunctivitis.
Jae Chan Kim, Ho Keol Lee, Hak Soo Lee, Woo Jae Lee, Do Hyung Lee, Kyung Hwan Shyn
Department of Ophthalmology, College of Medicine, Chungang University, Seoul, Korea.
유행성 각결막염에 대한 유전자 재조합 알파 인터페론의 치료효과
김재찬(Jae Chan Kim),이호걸(Ho Keol Lee),이학수(Hak Soo Lee),이우재(Woo Jae Lee),이도형(Do Hyung Lee),신경환(Kyung Hwan Shyn)
Abstract
We investigated the clinical effects and drug toxicities of high concentrated recombinant human alpha-interferon eyedrops in acute epidemic keratoconjunctivitis(ARK). We examined the side effects of alpha-interferon eyedrops after instillation to the 34 general healthy patients, and compared the clinical effects after randomized blind administration of the different concentration eyedrops or placebo in 117 AEK. No significant ocular complications in the 34 general healthy patients was observed. In AEK, improvement of symptoms and signs were observed at the mean 3.2 days of 10.000 IU/ml group, 3.1 days of 100,000 IU/ml group, and 3.2 days of 500,000 IU/ml group after instillation of alpha-interferon. comparing 4.4 days of placebo(P<0.01). We have also observed early absorption of conjunctival pseudomembrane, and the decreased incidence of keratitis. We suggest that the topical application of alpha-interferon might be clinically useful to help early recovery and decrease the incidence of ocular complications of AEK.
Key Words: alpha-interferon;AEK;Early recovery;High concentrated


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603    Fax: +82-2-2277-5194    E-mail: kos@ijpnc.com                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next